跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 志彥
教授
醫學系內科學科
電子郵件
chency
vghtpe.gov
tw
h-index
h10-index
h5-index
3022
引文
28
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
365
引文
11
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
143
引文
7
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1995 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(135)
類似的個人檔案
(6)
指紋
查看啟用 Chih-Yen Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
2 Receptor
16%
Acute Pancreatitis
15%
Acylated Ghrelin
16%
After Surgery
24%
Antrum
20%
Bariatric Surgery
24%
Body Mass Index
19%
Chinese Population
17%
Colonic Motility
20%
Colonic Secretion
28%
Conscious Rat
38%
Corticotropin-releasing Hormone Receptor 2
16%
Des-acyl Ghrelin
100%
Diarrhea-predominant Irritable Bowel Syndrome
18%
Dominant Frequency
15%
Duodenal Ulcer
23%
Duodenum
25%
Food Intake
37%
Gastric Bypass
46%
Gastric Emptying
50%
Gastric Motility
17%
Gastric Sleeve
20%
Gastrointestinal Motility
52%
Gastrointestinal Transit
26%
Ghrelin
69%
Gut Hormones
25%
Gut Motility
26%
Helicobacter Pylori (H. pylori)
32%
Hepatocellular Carcinoma
21%
Irritable Bowel Syndrome
27%
Metabolic Surgery
32%
Motility
29%
Obestatin
57%
Omeprazole
22%
Oriental Studies
16%
Orocecal Transit Time
19%
Power Ratio
15%
Remission
15%
Risk Factors
19%
Rome II
18%
Sleeve Gastrectomy
52%
Slow Wave
19%
Small Bowel Transit
17%
Social Impact
16%
Solid Gastric Emptying
18%
Stomach
53%
Taiwan
45%
Total Gastrectomy
21%
Type 2 Diabetes Mellitus (T2DM)
44%
Type 2 Diabetic Patients
25%
Medicine and Dentistry
Abdominal Cancer
14%
Acute Pancreatitis
16%
Bariatric Surgery
24%
Bleeding
15%
Body Mass Index
21%
Colon
9%
Colonic Secretion
16%
Constipation
10%
Corticotropin Releasing Factor
12%
Diabetes
14%
Duodenum
10%
Duodenum Ulcer
11%
Electrogastrogram
15%
Food Intake
38%
Gastrectomy
13%
Gastric Bypass
40%
Gastric Bypass Surgery
40%
Gastric Inhibitory Polypeptide
10%
Gastrointestinal Hormone
28%
Gastrointestinal Motility
31%
Ghrelin
76%
Gut
26%
Helicobacter Pylori
16%
Hepatitis B Virus
9%
Hepatocellular Carcinoma
21%
Inflammatory Arthritis
10%
Ingestive Behaviors
10%
Insulin Release
10%
Intracerebroventricular Drug Administration
9%
Irritable Bowel Syndrome
22%
Jejunum Ulcer
10%
Liver Cirrhosis
11%
Lower Gastrointestinal Bleeding
10%
Maturity Onset Diabetes of the Young
55%
Neoplasm
10%
Nesfatin-1
11%
Obestatin
25%
Patient with Type 2 Diabetes
23%
Prevalence
11%
Pylorus
16%
Receptor
17%
Rheumatoid Arthritis
10%
Rhythm
9%
Sensation
10%
Sleep Quality
10%
Sleeve Gastrectomy
40%
Sphincter
13%
Stomach Acid
22%
Stomach Emptying
48%
Stomach Motility
9%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Acid
7%
Cholelithiasis
10%
Constipation
8%
Corticotropin Releasing Factor
17%
Corticotropin Releasing Factor Receptor 2
8%
Dexamethasone
5%
Diabetic Obesity
10%
Diarrhea
14%
Digestive System Function Disorder
6%
Duodenum Ulcer
18%
Endothelin 1
8%
Etanercept
10%
Fatty Liver
8%
Fibroblast Growth Factor 19
10%
Gastric Inhibitory Polypeptide
6%
Gastroesophageal Reflux
5%
Gastrointestinal Hormone
8%
Ghrelin
65%
Heartburn
7%
Helicobacter Infection
7%
Helicobacter Pylori
24%
Hepatitis B Virus
5%
Infection
8%
Inflammatory Arthritis
10%
Interleukin 6
5%
Intermedin
6%
Intestine Flora
6%
Irritable Colon
33%
Liver Cell Carcinoma
10%
Liver Cirrhosis
5%
Nitrite
7%
Non Insulin Dependent Diabetes Mellitus
37%
Nonalcoholic Fatty Liver
10%
Normal Human
12%
Obestatin
29%
Octanoic Acid
5%
Omeprazole
24%
Pancreas Polypeptide
10%
Polyp
8%
Prevalence
12%
Receptor
20%
Reflux Esophagitis
6%
Remission
20%
Rheumatoid Arthritis
10%
Stomach Acid
16%
Tumor Necrosis Factor
7%
Ulcer
7%
Ulcer Healing
6%
Urocortin
6%
Urocortin III
6%
